title: [Erythropoiesis-stimulating agents in congestive heart failure patients].
abstract: Congestive heart failure is a disease of high incidence and prevalence in the elderly. Anemia is associated with an increased mortality in these patients. This article reviews the cumulated evidence about the use of erythropoiesis-stimulating agents in congestive heart failure patients. Although some improvement in quality of life has been shown, it has not been found any decrement on mortality and, as a result, together with the high drug cost, it is not recommended the use of this kind of drugs in heart failure patients.
authors.affiliation: Cátedra de Riesgo Cardiovascular, Universidad de Salamanca, Salamanca, España. Electronic address: nrrobles@yahoo.es.
authors.forename: Nicolás Roberto
authors.initials: NR
authors.lastname: Robles Perez-Monteoliva
authors.affiliation: Cátedra de Riesgo Cardiovascular, Universidad de Salamanca, Salamanca, España.
authors.forename: Juan Francisco
authors.initials: JF
authors.lastname: Macías Núñez
authors.affiliation: Servicio de Nefrología, Hospital General de Asturias, Oviedo, Asturias, España.
authors.forename: Julio
authors.initials: J
authors.lastname: Herrera Pérez de Villar
mesh_terms: D000740:Anemia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D006333:Heart Failure / Q000150:complications* / Q000401:mortality; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D006397:Hematinics
keywords: Agentes estimulantes de la eritropoyesis; Anemia; Erythropoiesis-stimulating agents; Heart failure; Insuficiencia cardiaca